Your browser doesn't support javascript.
loading
Hemophagocytic Lymphohistiocytosis Due to Primary HHV-8 Infection in a Liver Transplant Recipient.
Cohen, Gabriel M; Langer, Arielle L; Sima, Hamid; Chang, Charissa; Troy, Kevin; Taimur, Sarah.
Afiliação
  • Cohen GM; Division of Infectious Diseases, New York University School of Medicine, New York, NY.
  • Langer AL; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Sima H; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Chang C; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Troy K; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Taimur S; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY.
Transplant Direct ; 4(12): e411, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30584592
ABSTRACT
Human herpesvirus-8 (HHV-8) remains best known as an oncogenic virus, but nonneoplastic disease manifestations, such as bone marrow failure or hemophagocytic lymphohistiocytosis (HLH) have gained greater recognition in recent years. In organ transplantation, HHV-8 infection commonly occurs with reactivation of latent virus among recipients from endemic regions of the world or due to transmission from the organ donor. We describe a case of HHV-8-associated HLH in a liver transplant recipient at increased risk for primary infection. Our case highlights the risk of non-donor-derived, posttransplant primary HHV-8 infection, and demonstrates that HLH can be a life-threatening complication of this infection.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article